MVIS® Global Future Healthcare ESG Index
The MVIS® Global Future Healthcare ESG Index (MVFHC) is a global index that tracks the performance of companies that are involved in the genomic health care and electronic healthcare industries. The index is a modified market cap-weighted index with pure-play exposure. MVFHC covers at least 90% of the investable universe.
Country Weightings
Country weightings are based on the weightings of all index components in a certain country.
| Country | Components | Weight |
| United States | 38 | 76.83% |
| Belgium | 1 | 0.56% |
| Germany | 2 | 5.51% |
| Netherlands | 3 | 3.78% |
| Sweden | 1 | 0.57% |
| Switzerland | 1 | 1.07% |
| United Kingdom | 2 | 1.33% |
| Australia | 1 | 0.84% |
| Japan | 1 | 3.39% |
| Bermuda | 1 | 1.48% |
| Cayman Islands | 3 | 4.65% |
| Total | 54 | 100.00% |
| Sector | Components | Weight |
| Materials | 1 | 0.18% |
| Consumer Staples | 4 | 5.45% |
| Health Care | 49 | 94.37% |
| Total | 54 | 100.00% |
Size Weightings
- Large-Cap: companies with a market capitalisation above 6,000 mln
USD
- Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln
USD
- Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln
USD
- Micro-Cap: companies with a market capitalisation up to 200 mln
USD
| Size | Market Cap | Components | Weight |
| Large-Cap | 506,253,807,000 USD | 17 | 75.77% |
| Mid-Cap | 97,504,942,300 USD | 31 | 22.99% |
| Small-Cap | 5,333,237,650 USD | 6 | 1.24% |
| Micro-Cap | - | - | - |
| Total | 609,091,986,950 USD | 54 | 100.00% |
